Preventing and Managing Visual Disability in Primary Care: Clinical Applications

JAMA

Volumn 291, Issue 12, 2004, Pages 1497-1502

  Goldzweig, Caroline L ^a,b,e   Rowe, Susannah ^c   Wenger, Neil S ^b   MacLean, Catherine H ^b,d   Shekelle, Paul G ^a,b,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RAND CORPORATION   (United States)

^e Nephrology Section (1111)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; AGENTS ACTING ON THE EYE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BORIC ACID; BRIMONIDINE; CARTEOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DIPIVEFRINE; ECOTHIOPATE; LEVOBUNOLOL; METIPRANOLOL; NAPHAZOLINE; PHENYLEPHRINE; PILOCARPINE; TIMOLOL; VASOCONSTRICTOR AGENT;

ALLERGIC CONJUNCTIVITIS; ANXIETY DISORDER; BRADYCARDIA; BREATHING DISORDER; BRONCHOSPASM; CATARACT; CONVERGENT STRABISMUS; DEPRESSION; DISEASE EXACERBATION; DIZZINESS; FLUSHING; GLAUCOMA; HEADACHE; HEALTH PRACTITIONER; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE EXTRASYSTOLE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOTENSION; LETHARGY; LIBIDO DISORDER; LUNG DISEASE; MYDRIASIS; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REFRACTION ERROR; REVIEW; RISK FACTOR; SIDE EFFECT; SOMNOLENCE; SYNCOPE; TACHYCARDIA; TREMOR; VISION TEST; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT; VOMITING; WHEEZING; XEROSTOMIA; AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; EYE DISEASE; FEMALE; GENERAL PRACTICE; MALE; MIDDLE AGED; RETINA MACULA DEGENERATION; SMOKING; STANDARD;

AGED; DIABETES MELLITUS; EYE DISEASES; FAMILY PRACTICE; FEMALE; GLAUCOMA; HUMANS; HYPERTENSION; MACULAR DEGENERATION; MALE; MIDDLE AGED; SMOKING; VISION SCREENING; VISUAL ACUITY;

EID: 1642400659     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.12.1497     Document Type: Review

References (46)

1. Rowe S, MacLean CM, Shekelle PG. Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA. 2004;291:1487-1496.
2. National Committee for Quality Assurance. Diabetes Quality Improvement Project Initial Measure Set (final version): synopsis of the DQIP Initial Measure Set. Available at: http://www.ncqa.org/dprp/dqlp2.htm#synopsis. Accessed February 19, 2004.
3. Veterans Affairs/Department of Defense Clinical Practice Guideline Working Group. Management of Diabetes Mellitus. Washington, DC: Office of Quality and Performance; 1999.
4. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, X: four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989;107:244-249.
5. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy, XIV: ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
6. Eke T, Reddy MA, Karwatowski WS. Glaucoma awareness and screening uptake in relatives of people with glaucoma. Eye. 1999;13:647-649.
7. Gasch AT, Wang P, Pasquale LR. Determinants of glaucoma awareness in a general eye clinic. Ophthalmology. 2000;107:303-308.
8. Livingston PM, McCarty CA, Taylor HR. Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol. 1998;82:780-785.
9. Pasagian-Macaulay A, Basch CE, Zybert P, Wylie-Rosett J. Ophthalmic knowledge and beliefs among women with diabetes. Diabetes Educator. 1997;23:433-437.
10. Sudesh S, Downes SM, McDonnell PJ. Audit of patients' awareness of ophthalmic diagnoses. Qual Health Care. 1993;2:175-178.
11. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
12. Walker EA, Basch CE, Howard CJ, et al. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications. 1997;11:298-306.
13. Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001;108:563-571.
14. Buonaccorso KM. Diabetic retinopathy screening: a clinical quality improvement project. J Healthc Qual. 1999;21:35-38, discussion 46.
15. Philis-Tsimikas A, Walker C. Improved care for diabetes in underserved populations. J Ambul Care Manage. 2001;24:39-43.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
17. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
18. Chobanian AV, Bakris GL, Black HR, et al, for National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
19. Cheng AC, Pang CP, Leung AT, et al. The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000;6:195-202.
20. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079-1084.
21. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156-163.
22. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study. Ophthalmology. 2000;107:2224-2232.
23. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age-related cataract in men. JAMA. 2000;284:713-716.
24. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy: the Seaver Dam Eye Study. Am J Epidemiol. 1998;147:103-110.
25. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704.
26. Weintraub JM, Willett WC, Rosner B, et al. Smoking cessation and risk of cataract extraction among US women and men. Am J Epidemiol. 2002;155:72-79.
27. American Optometric Association Consensus Panel on Comprehensive Adult Eye and Vision Examination. Comprehensive adult eye and vision examination. Available at: http://www.aoa.org/eweb/Documents/1.pdf. Accessed February 25, 2004.
28. American Academy of Ophthalmology. Comprehensive Medical Eye Evaluation. San Francisco, Calif: American Academy of Ophthalmology; 2000.
29. Trobe J. The Physician's Guide to Eye Care. 2nd ed. San Francisco, Calif: American Academy of Ophthalmology; 2001.
30. Drug Facts and Comparisons. St Louis, Mo: Walters Kluwer Health Inc; 2003.
31. Lee PP, Spritzer K, Hays RD. The impact of blurred vision on functioning and well-being. Ophthalmology. 1997;104:390-396.
32. Elliott DB, Patla A, Bullimore MA. Improvements in clinical and functional vision and perceived visual disability after first and second eye cataract surgery. Br J Ophthalmol. 1997;81:889-895.
33. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784.
34. Ivers RQ, Mitchell P, Cumming RG. Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. Clin Exp Ophthalmol. 2000;28:41-47.
35. Klein BE, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time: the Beaver Dam Eye Study. Ophthalmology. 199B;105:160-164.
36. Lee P, Smith JP, Kington R. The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older. Am J Ophthalmol. 1999;127:447-452.
37. Lee PP, Smith JP, Kington RS. The associations between self-rated vision and hearing and functional status in middle age. Ophthalmology. 1999;106:401-405.
38. Abrahamsson M, Carlsson B, Tornqvist M, et al. Changes of visual function and visual ability in daily life following cataract surgery. Acta Ophthalmol Scand. 1996;74:69-73.
39. Lee PP, Whitcup SM, Hays RD, et al. The relationship between visual acuity and functioning and well-being among diabetics. Qual Life Res. 1995;4:319-323.
40. Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999;128:45-53.
41. Mangione CM, Phillips RS, Lawrence MG, et al. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 1994;112:1419-1425.
42. Mangione CM, Phillips RS, Seddon JM, et al. Development of the Activities of Daily Vision Scale: a measure of visual functional status. Med Care. 1992;30:1111-1126.
43. Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev [serial online]. 2003;1:CD001054.
44. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119:1417-1436.
45. Brody BL, Roch-Levecq AC, Gamst AC, et al. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol. 2002;120:1477-1483.
46. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120:1041-1044.